Your browser doesn't support javascript.
loading
Trained innate immunity, long-lasting epigenetic modulation, and skewed myelopoiesis by heme.
Jentho, Elisa; Ruiz-Moreno, Cristian; Novakovic, Boris; Kourtzelis, Ioannis; Megchelenbrink, Wout L; Martins, Rui; Chavakis, Triantafyllos; Soares, Miguel P; Kalafati, Lydia; Guerra, Joel; Roestel, Franziska; Bohm, Peter; Godmann, Maren; Grinenko, Tatyana; Eugster, Anne; Beretta, Martina; Joosten, Leo A B; Netea, Mihai G; Bauer, Michael; Stunnenberg, Hendrik G; Weis, Sebastian.
Afiliação
  • Jentho E; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Friedrich-Schiller-University, 07747 Jena, Germany.
  • Ruiz-Moreno C; Instituto Gulbenkian de Ciência, 2780-156 Oeiras, Portugal.
  • Novakovic B; Prinses Máxima Centrum for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
  • Kourtzelis I; Science Faculty, Department of Molecular Biology, Radboud University, 6525 GA Nijmegen, The Netherlands.
  • Megchelenbrink WL; Science Faculty, Department of Molecular Biology, Radboud University, 6525 GA Nijmegen, The Netherlands.
  • Martins R; Department of Paediatrics, Murdoch Children's Research Institute, University of Melbourne, Parkville VIC 3052, Australia.
  • Chavakis T; Institute of Clinical Chemistry and Laboratory Medicine, University Clinic Dresden, Technische Universität Dresden, 01307 Dresden, Germany.
  • Soares MP; National Center for Tumor Diseases, Partner Site Dresden, German Cancer Research Center, 69120 Heidelberg, Germany.
  • Kalafati L; Hull York Medical School, York Biomedical Research Institute, University of York, York YO10 5NG, United Kingdom.
  • Guerra J; Prinses Máxima Centrum for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
  • Roestel F; Department of Precision Medicine, University of Campania Luigi, 80138 Naples, Italy.
  • Bohm P; Instituto Gulbenkian de Ciência, 2780-156 Oeiras, Portugal.
  • Godmann M; Institute of Clinical Chemistry and Laboratory Medicine, University Clinic Dresden, Technische Universität Dresden, 01307 Dresden, Germany.
  • Grinenko T; Instituto Gulbenkian de Ciência, 2780-156 Oeiras, Portugal.
  • Eugster A; Institute of Clinical Chemistry and Laboratory Medicine, University Clinic Dresden, Technische Universität Dresden, 01307 Dresden, Germany.
  • Beretta M; National Center for Tumor Diseases, Partner Site Dresden, German Cancer Research Center, 69120 Heidelberg, Germany.
  • Joosten LAB; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Friedrich-Schiller-University, 07747 Jena, Germany.
  • Netea MG; Center for Sepsis Control and Care, Jena University Hospital, Friedrich-Schiller-University, D-07747 Jena, Germany.
  • Bauer M; Institute for Infectious Disease and Infection Control, Jena University Hospital, Friedrich-Schiller-University, 07747 Jena, Germany.
  • Stunnenberg HG; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Friedrich-Schiller-University, 07747 Jena, Germany.
  • Weis S; Institute for Infectious Disease and Infection Control, Jena University Hospital, Friedrich-Schiller-University, 07747 Jena, Germany.
Proc Natl Acad Sci U S A ; 118(42)2021 10 19.
Article em En | MEDLINE | ID: mdl-34663697
ABSTRACT
Trained immunity defines long-lasting adaptations of innate immunity based on transcriptional and epigenetic modifications of myeloid cells and their bone marrow progenitors [M. Divangahi et al., Nat. Immunol. 22, 2-6 (2021)]. Innate immune cells, however, do not exclusively differentiate between foreign and self but also react to host-derived molecules referred to as alarmins. Extracellular "labile" heme, released during infections, is a bona fide alarmin promoting myeloid cell activation [M. P. Soares, M. T. Bozza, Curr. Opin. Immunol. 38, 94-100 (2016)]. Here, we report that labile heme is a previously unrecognized inducer of trained immunity that confers long-term regulation of lineage specification of hematopoietic stem cells and progenitor cells. In contrast to previous reports on trained immunity, essentially mediated by pathogen-associated molecular patterns, heme training depends on spleen tyrosine kinase signal transduction pathway acting upstream of c-Jun N-terminal kinases. Heme training promotes resistance to sepsis, is associated with the expansion of self-renewing hematopoetic stem cells primed toward myelopoiesis and to the occurrence of a specific myeloid cell population. This is potentially evoked by sustained activity of Nfix, Runx1, and Nfe2l2 and dissociation of the transcriptional repressor Bach2. Previously reported trained immunity inducers are, however, infrequently present in the host, whereas heme abundantly occurs during noninfectious and infectious disease. This difference might explain the vanishing protection exerted by heme training in sepsis over time with sustained long-term myeloid adaptations. Hence, we propose that trained immunity is an integral component of innate immunity with distinct functional differences on infectious disease outcome depending on its induction by pathogenic or endogenous molecules.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mielopoese / Epigênese Genética / Heme / Imunidade Inata Limite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mielopoese / Epigênese Genética / Heme / Imunidade Inata Limite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2021 Tipo de documento: Article